| PET | Positron emission tomography |
| FDG | 18F-fluorodeoxyglucose |
| mAb | Monoclonal antibody |
| DFO | Desferrioxamine B |
| NP | Nanoparticle |
| FDA | Food and Drug Administration |
| HER2 | Human epidermal growth factor receptor-2 |
| EGFR | Epidermal growth factor receptor |
| VEGF-A | Vascular endothelial growth factor-A |
| CD | Cluster of differentiation |
| PSMA | Prostate specific membrane antigen |
| PD-L1 | Programmed cell death ligand-1 |
| PD-1 | Programmed cell death protein-1 |
| ADCs | Antibody–drug conjugates |
| T-DM1 | Trastuzumab emtansine |
| SUV | Standardized uptake value |
| CD44v6 | v6 splice variant of CD44 |
| TAM | Tumor-associated macrophages |
| HDL | High-density lipoprotein |
| CAR | Chimeric antigen receptor |
| DBN | Desferrioxamine-N-chlorosuccinimide |
| hMSC | Human mesenchymal stem cells |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.